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Rheumatoid arthritis (RA) is an autoimmune disease characterized by proliferative synovial tissue.
We used mRNA differential display and library subtraction to compare mRNA expression in RA and
osteoarthritis (OA) synoviocytes. We initially compared the mRNA expression patterns in 1 female RA
and 1 OA synovia and found a differentially expressed 350bp transcript in the RA synoviocytes which
was, by sequence analysis, 100% homologous to sperm protein 17 (Sp17). Moreover, the Sp17
transcript was found differentially expressed in a RA synovial library that was subtracted with an OA
synovial library. Using speciﬁc primers for full length Sp17, a 1.1kb transcript was ampliﬁed from the
synoviocytes of 7 additional female RA patients, sequenced and found to 100% homologous to Sp17.
Thus, we found the unexpected expression of Sp17, a thought to be gamete-speciﬁc protein, in the
synoviocytes of 8/8 female RA patients in contrast to control OA synoviocytes. Interestingly, Sp17’s
structural relationship with cell-binding and recognition proteins, suggests that Sp17 may function in
cell–cell recognition and signaling in the RA synoviocyte. Further, Sp17 could have a signiﬁcant
regulatory role in RA synoviocyte gene transcription and/or signal transduction. Thus, Sp17 could have
an important role in RA synoviocyte proliferation or defective apoptosis. Finally, the presence of Sp17
in synoviocytes has interesting developmental considerations.
Keywords: Gene expression; Rheumatoid arthritis; Sperm protein 17; Developmental biology
INTRODUCTION
Rheumatoid arthritis (RA) is an autoimmune disease
characterized by proliferative synovial tissue, including
proliferating synoviocytes and subsynovial tissue inﬁl-
trated with lymphoid and other immune cells. However,
our current understanding of the pathogenic mechanisms
operative in RA synovitis is incomplete. T cells, B cells,
macrophages, cytokines, MHC antigens and other gene
products are important in RA as is synoviocyte
proliferation and the subsequent destruction of articular
cartilage and bone (Goronzy and Weyand, 1997; Imamura
et al., 1998). Understanding the mechanisms responsible
for synoviocyte hyperplasia, e.g. proliferation versus
defective apoptosis, is necessary to better understand RA.
Sperm protein (Sp17) is a highly conserved and
autoantigenic protein that was originally cloned,
sequenced and characterized as the 17kD member of
the rabbit sperm autoantigen family of Sp (O’Rand et al.,
1988; Richardson et al., 1994). Sp17 functions in the
binding of sperm to zona pellucida (O’Rand and Widgren,
1994). The Sp17 gene has also been found in the mouse,
rat, monkey, dog, baboon and humans (Lea et al., 1996)
and data initially indicated that Sp17 was testes-speciﬁc
by Northern blot analysis and localized in the cytoplasm
of spermatogenic cells of testes (Adoyo et al., 1997).
However, recently Sp17 has been found in some lymphoid
tissue and certain malignancies (Dong et al., 1997),
suggesting that Sp17 belongs to a new family of
molecules, the cancer-testes antigen (CTS).
Sp17 has a peptide structure which shares homology
and motifs with cell-junctional proteins. The motifs of
Sp17 include: a protein kinase A region, a sulfate binding
region, and a calmodulin binding site (Yamasaki et al.,
1995). Thus, Sp17 may have an important role in
uncontrolled cell proliferation.
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tive, we compared the mRNA expression patterns in RA
and osteoarthritis (OA) synoviocytes using differential
display and library subtraction. Interestingly, we found
a differentially expressed 350 base pair transcript in
the RA synoviocytes which was 100% homologous to
Sp17. Moreover, we demonstrated the highly unexpected
differential mRNA expression of Sp17 in the synoviocytes
of 8/8 female RA patients. Further, indomethacin and
Neurotropin, which has been reported to have beneﬁcial
effects in animals with immune abnormality (Naiki et al.,
1989; 1991; Kato et al., 1991), inhibited Sp17
gene expression in RA synoviocytes, whereas dexametha-
sone had no effect on Sp17 gene expression in RA
synoviocytes.
MATERIALS AND METHODS
Preparation of Synovial Cells (SC)
Synovial tissue was obtained incidental to clinically
indicated surgical procedures (synovectomy, total joint
replacement) on seropositive RA patients, as previously
described (Ermel et al., 1997). Human synovium was cut
into small 5-mm pieces and digested with collagenase
(EC 3.4.24.3; Type IA, Sigma Chemical Co., St. Louis,
MO, USA)and deoxyribonuclease I(EC 3.1.21.1; DNase I
Type IV, Sigma Chemical). Single cells were decanted
from the undigested material and washed in Hank’s
balanced salt solution (HBSS) (JRH Laboratory,
Woodland, CA, USA). Synovial cells (SC) were
resuspended in Dulbecco’s modiﬁed MEM.F12 (D/F12)
medium (JRH Laboratory) containing 10% fetal calf
serum (FCS) and gentamicin (Sigma Chemical)
to 5000cells/ml and 24 well plates (Corning, Corning,
NY, USA) were seeded with 2ml of SC. Seeded and
incubated SC were trypsinized and passed. After two or
three passages, the cultured RA-SC were ﬁbroblast-like
SC. Eight RA-SC lines were isolated from 8 different
female synovia.
Agents
Dexamethasone (dexamethasone–water soluble) and
indomethacin were obtained from Sigma Chemical,
St. Louis, MO. Indomethacin was dissolved in ethanol
and diluted with the medium as described later. Ethanol
was used at 0.005% in the culture medium. Dexametha-
sone and indomethacin were used at concentrations of
10
26M. Neurotropine, which is a unique non-protein
extract isolated from a inﬂamed dermis of rabbits
inoculated with vaccinia virus, was obtained from Nippon
Zoki Pharmaceutical Co., Ltd. (Osaka, Japan). It has been
also clinically used as an analgesic and as an anti-allergy
drug with few side effects in humans. Neurotropin was
diluted with medium at concentrations of 0.1 or 0.01
Neurotropin unit/ml.
Cell Culture
Wellswereallowedtogrowto75%conﬂuence.Passedand
incubatedSCwerewashed threetimeswith HBSS.One ml
of D/F12 medium without FCS was pipetted into each
well, and cultured for 1day to synchronize the cell cycle.
The medium was changed to D/F12 medium with 10% of
FCS. At this time, 10
26Mo fd e x a m e t h a s o n eo r
indomethacin, or 0.1 or 0.01unit/ml of Neurotropin was
added to the wells. Saline was diluted 1:1000 in culture
medium as a control. The control for indomethacin
contained 0.005% of ethanol in culture medium as
mentioned above. The cells were harvested after culture
for 3days.
RNA Preparation and Removal of DNA
Contamination from RNA
At the desired time points, the cells were washed twice
with PBS, and 1.0ml of Isogen (Wako Chemical Industry,
Osaka, Japan) was added directly to the cells for the
isolation of total RNA. Total RNAwas prepared from the
cultured cells using the acid guanidine thiocyanate-
phenol/chloroform method.
Total cell RNA (50mg) was treated with 10units of
DNase I to remove chromosomal DNA contaminants from
the RNA sample obtained by using the protocols from
GenHunter (Message Clean kit; GenHunter, Brookline,
MA, USA). After extraction with phenol/chloroform and
ethanol precipitation with 3M NaOAC, the RNA was
redissolved in DEPC-treated water. The redissolved RNA
samples were quantitated by OD260 after 1:1000 dilution,
and puriﬁed RNA samples (1–2mg/ml) were stocked at
2808C until ready for use.
mRNA Differential Display
Puriﬁed RNA samples (0.1mg/ml) were reverse-trans-
cribed with one of the one-base-anchored H-T11G primer
(50-AAGCTTTTTTTTTTTG-30) using MMLV reverse
transcriptase according to the manufacturer’s instructions
(RNAimage: GenHunter). The reverse-transcribed cDNA
was PCR-ampliﬁed in combination with the 500 arbitrary
primer (50-AAGCTTCATTCCG-30)a n dt h eH - T 1 1 G
primer. The cycling parameters were as follows: 948C
for 30s, 458C for 2min, 728C for 30s for 40 cycles,
followed by 728C for 5min. The cDNAs were labeled with
[
35S]-dATP (NEN, Boston, MA, USA). The ampliﬁed
cDNAs were separated on a 6% acrylamide sequencing
gel. [
35S] labeled cDNAs were exposed to X-ray ﬁlm
(Fuji, Tokyo, Japan).
Differentially displayed cDNAs were excised from
the dried sequencing gel, recovered and reampliﬁed in a
reaction volume of 40ml for 40 cycles under the same
conditions mentioned above. Reampliﬁed PCR products
were cloned into the PCR II vector. DNA sequence
analysis was carried out using Taq DyeDeoxy Terminator
Cycle Sequencing Kit (Applied Biosystems, Foster City,
Y. TAKEOKA et al. 98CA, USA). The samples were sequenced on the ABI373A
DNA sequencer (Applied Biosystems) and were auto-
matically recorded and analyzed using Genescan 672
software.
RNA-based Primed PCR
RA-SC were harvested for RNA extraction when cultures
reached about 75% conﬂuence. Total RNAs were prepared
by Isogen (Wako Chemical Industry). The puriﬁed RNA
from RA-SC were reverse transcribed using either speciﬁc
primers for Sp17 50UTR (50-GATGTGGTCAAGGAGCG-
AATC-30)orCDS(50-ATTCTGAGAGAGCAACCGGAC-
30)andsubsequentlyampliﬁedbyPCRusingeitherspeciﬁc
primer combinations for Sp17 50UTR (50-GATGTGGTC-
AAGGAGCGAATC and 30-GCAGTCAGACACACT-
TGAC), or CDS (50-ATTCTGAGAGAGCAACCGGAC
and 30-GAGTCTAAGATGGTGACTGATG). The PCR
productswereseparatedby1.5%agarosegelwithethidium
bromide, and were detected under ultra violet.
RESULTS
mRNA Differential Display of RA and OA
Synoviocytes and Identiﬁcation of Sp17
We initially found the differential expression of Sp17
mRNA using differential display and conﬁrmed by library
subtraction between a female RA patient’s and an OA
patient’s synoviocytes. Figure 1 shows the sequence
homologyoftheampliﬁedtranscript,wedesignatedYu41,
and it’s best match to gene sequences searched using
Genbank. There was a 99.43% homology to the 30 coding
region and UTR of human Sp17. Because of the size of the
bandampliﬁedbydifferentialdisplay,wewereonlyableto
sequence the 30 end of the Sp17 gene. Therefore, we then
FIGURE 1 Homology of the ampliﬁed and sequenced cDNA transcript, Yu 41, to Sp17, the best match in Genbank.
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the remainder of the Sp17 gene from the RA synoviocytes.
Figure 2 shows the respective bands ampliﬁed. Sequence
analysis indicated that the band in lane 1 was 100%
homologouswiththe50 UTRandthebandinlane2withthe
coding region of Sp17.
We then examined synoviocytes obtained from eight
female RA patients and one additional OA patient by PCR
ampliﬁcation using our Sp17 speciﬁc primers. All 8 of
the RA patients synoviocytes were strongly positive for
Sp17 gene expression. Although PCR ampliﬁcation of
Sp17 in the OA patient’s synoviocytes showed the
presence of the Sp17 gene expression, it was barely
positive (data not shown).
Sp17 Expression and Modulation in RA Synoviocytes
We next examined modulation of Sp17 gene expression in
RA synoviocytes by dexamethasone, indomethacin, and
Neurotropin. Figure 3 is a representative example of such
modulation. Lane 1 shows control RA synoviocyte Sp17
expression.Lane2showstheeffectof0.005%ethanol,asa
control, which was used to solubilize indomethacin.
Lanes 3 and 4 show the inhibition effect of different
concentrations of Neurotropin on Sp17 gene expression
while Lane 5 shows the inhibitory effect of indomethacin,
andLane6shows thelackofinhibitionbydexamethasone.
Thus, both Neurotropin and indomethacin inhibited Sp17
gene expression in RA synoviocytes but dexamethasone
did not.
DISCUSSION
Sp17 is a highly conserved autoantigenic protein that was
originally described as the 17kDa member of the rabbit
sperm autoantigen family of sperm proteins. Sp17 was
cloned, sequenced and characterized in the rabbit as an
autoantigen that functions in the binding of sperm to zona
pellucida (O’Rand et al., 1988; O’Rand and Widgren,
1994; Richardson et al., 1994;). The Sp17 gene is also
found in the mouse, rat, monkey, dog, baboon and humans
but not in chicken or yeast (Lea et al., 1996). Data initially
indicated that Sp17 was testes-speciﬁc by Northern blot
analysis and is localized in the cytoplasm of resting
spermatogenic cells of the testes (Adoyo et al., 1997).
More recently, however, the Sp17 gene was found in
sheep mucosa associated lymphoid tissue, the metastatic
stage of a murine squamous cell carcinoma model,
multiple myeloma and malignant lymphocytes (Dong
et al., 1997). Thus, it is likely that Sp17 is a member of a
new family of molecules, CTS. These observations,
coupled with the molecular structure of Sp17, suggest an
important role in unregulated cell proliferation.
FIGURE 2 This ﬁgure shows the respective bands ampliﬁed using speciﬁc primers from RA synviocytes. (A) Lane 1: 1.6 50UTR 50-
GATGTGGTCAAGGAGCGAATC; 30-GCAGTCACTGACACACTTGAC. (B) Lane 2:C D S ,5 0-ATTCTGAGAGAGCAACCGGAC;
30-GAGTCTAAGATGGTGACTGATG. Analysis indicated that the band in lane 1 was 100% homologous with the 50 UTR and the band in lane 2
homologous with the coding region of Sp17. Lane M is the marker.
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effect on Sp17 gene expression in RA synoviocytes, both
indomethacin and Neurotropin inhibited expression of the
Sp17 gene. The effect of Neurotropin is unknown but may
be able to improve abnormalities autoimmune murine
models (Naiki et al., 1989; 1991; Kato et al., 1991) and
kallikreinkinin-ﬁbrinolytic cascades in inﬂammation
(Nishikawa et al., 1992). On the other hand, it is well
established that indomethacin and other NSAIDs inhibit
gene expression in certain cancer cells such as colorectal
and lung cancer (Pan et al., 2001; Husain et al., 2002), and
the egr-1 gene in endothelial cells which promotes
angiogenesis (Szabo et al., 2001). It is, therefore, not
surprising that indomethacin inhibited Sp17 expression in
RA SC since they and cancer cells have in common,
unregulated proliferation.
At this time we do not know whether, Sp17 has a
functional role in the RA synoviocyte or whether, it is
merely an embryonal antigen. However, the molecular
structure of Sp17 strongly implies a functional role.
In particular, the cAMP dependent protein kinase II alpha
site suggests that Sp17 could be involved in regulation of
gene transcription within the synoviocyte. This could have
signiﬁcant pathogenic effects if Sp17 or a gene it regulates
were important in regulating proliferation or apoptosis.
Moreover, the protein kinase alpha site could also be
important in modulating signal transduction within the RA
synoviocyte. Furthermore, the sulfate binding site could
be important in binding polysaccharides produced within
the RA synovium and affect their function. Finally, the
calmodulin binding site could also allow Sp17 to
contribute to signal transduction within the RA
synoviocyte.
Therefore, although the function of Sp17 in the RA
synoviocyte is unknown, the molecular structure strongly
suggests that Sp17 may be linked to cell–cell communi-
cation, signal transduction, protein synthesis, regulation
of gene transcription, proliferation and/or defective
apoptosis. Further studies are indicated to better deﬁne
the function of Sp17 in the RA synovium. Moreover, this
study demonstrates the usefulness of mRNA differential
display to detect altered gene expression in RA and other
autoimmune diseases, and the potential usefulness of this
approach to identify candidate genes as chemotherapeutic
markers and targets.
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